Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma

被引:10
作者
Avigad, S
Benyaminy, H
Tamir, Y
Luria, D
Yaniv, I
Stein, J
Stark, B
Zaizov, R
机构
[1] Rabin Med Ctr, Schneider Childrens Med Ctr Israel, IL-49202 Petah Tikva, Israel
[2] Felsenstein Res Ctr, Schneider Childrens Med Ctr Israel, Petah Tikva, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
neuroblastoma; chromosome aberrations; p32; chromosome; 1; polymorphic markers; children;
D O I
10.1016/S0959-8049(97)00239-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thirty-six neuroblastomas were analysed for chromosome 1p alterations and their prognostic relevance. In 72% (26/36) of the patients, 1p alterations were identified in the tumours using 24 polymorphic loci ranging 1p22-1p36.3. LOH was identified in 25 children, and in 10 additional allelic imbalance was identified. In 1 child allelic imbalance was the sole alteration. Imbalance was termed as gain in intensity of one allele with or without reduction of the second allele (< 50%). The imbalance was identified in adjacent regions to the LOH. Two distinct regions of LOH were identified: 1p36.1-p36.3 and 1p31-p32. The common imbalance regions overlapped the common LOH regions. The children with LOH and imbalance had improved survival (100%) compared to the children with LOH only (26%) after 48 months of follow-up. The imbalance had an advantageous effect that is reflected by the improved outcome in children with other unfavourable clinical features. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:1983 / 1985
页数:3
相关论文
共 19 条
[1]  
AMLER LC, 1995, ONCOGENE, V10, P1095
[2]   MOLECULAR-BIOLOGY AND GENETICS OF HUMAN NEURO-BLASTOMA [J].
BRODEUR, GM ;
FONG, CT .
CANCER GENETICS AND CYTOGENETICS, 1989, 41 (02) :153-174
[3]  
BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO
[4]  
2-1
[5]  
CARON H, 1994, AM J HUM GENET, V55, P341
[6]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[7]   ALLELIC LOSS OF CHROMOSOME-1 AND ADDITIONAL CHROMOSOME-17 MATERIAL ARE BOTH UNFAVORABLE PROGNOSTIC MARKERS IN NEUROBLASTOMA [J].
CARON, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :215-221
[8]   COMPARISON OF DNA ANEUPLOIDY, CHROMOSOME-1 ABNORMALITIES, MYCN AMPLIFICATION AND CD44 EXPRESSION AS PROGNOSTIC FACTORS IN NEUROBLASTOMA [J].
CHRISTIANSEN, H ;
SAHIN, K ;
BERTHOLD, F ;
HERO, B ;
TERPE, HJ ;
LAMPERT, F .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) :541-544
[9]  
EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
[10]  
2-G